Overview

A Study to Evaluate Organ Level Uptake Repeatability of 124I AT-01 in Subjects With Systemic Amyloidosis

Status:
Recruiting
Trial end date:
2022-08-30
Target enrollment:
Participant gender:
Summary
This study is designed to assess the repeatability of organ-specific quantitation of radiotracer uptake following Positron Emission Tomography/Computed Tomography (PET/CT) imaging of AT- 01 in subjects with amyloid light chain (AL) or amyloid transthyretin (ATTR) systemic amyloidosis.
Phase:
Phase 2
Details
Lead Sponsor:
Attralus, Inc.